Aditxt, Inc. Proceeds from Secured Notes Payable
Aditxt, Inc. (ADTX) reported Proceeds from Secured Notes Payable of $1.25 million for the 3-month period ending 2023-03-31, per its 10-Q filed 2023-05-15.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromSecuredNotesPayable · last filed 2023-05-15
- Aditxt, Inc. proceeds from secured notes payable for the quarter ending 2023-03-31 was $1.25M.
- Aditxt, Inc. proceeds from secured notes payable for fiscal 2022 was $80.00K.
| Period end | Proceeds from Secured Notes Payable 3 month | Proceeds from Secured Notes Payable 12 month |
|---|---|---|
| 2023-03-31 | $1.25M 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $80.00K 10-K · filed 2023-04-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |